Tapering Engine

The tapering engine is the core operational system that manages GLP-1 medication reduction protocols. It operates autonomously within employer-defined policy constraints.

How it operates

The engine continuously assesses member cohorts for tapering eligibility based on metabolic stability, adherence history, and risk thresholds. Eligible members are enrolled in protocol-driven dose reduction workflows with clinical oversight.

Protocol execution

Tapering protocols are executed according to predefined clinical pathways. Dose reductions occur gradually with stability checkpoints. Members who exhibit metabolic instability are automatically exited to exception pathways.

Member communication

The engine manages member communication workflows including tapering notifications, progress updates, and exception alerts. Communication is structured, protocol-driven, and requires no client intervention.

Prescriber coordination

The engine coordinates with prescribers to execute dose changes. Prescriber workflows are managed through structured interfaces that minimize administrative burden while maintaining clinical oversight.

Oversight and intervention

Human clinical oversight is applied at predefined decision points where protocols require judgment. The engine operates autonomously for routine workflows. Exceptions requiring intervention are flagged and escalated automatically.